FORMIGARO, Luca
 Distribuzione geografica
Continente #
NA - Nord America 1.519
EU - Europa 458
AS - Asia 267
OC - Oceania 2
Totale 2.246
Nazione #
US - Stati Uniti d'America 1.519
CN - Cina 171
IT - Italia 108
DE - Germania 106
TR - Turchia 85
GB - Regno Unito 57
UA - Ucraina 55
SE - Svezia 49
BE - Belgio 27
FI - Finlandia 16
RU - Federazione Russa 12
FR - Francia 11
PL - Polonia 8
VN - Vietnam 5
IE - Irlanda 3
NL - Olanda 3
AU - Australia 2
ID - Indonesia 2
AT - Austria 1
EE - Estonia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
MK - Macedonia 1
UZ - Uzbekistan 1
Totale 2.246
Città #
Woodbridge 233
Fairfield 211
Ann Arbor 172
Chandler 118
Houston 111
Ashburn 94
Jacksonville 79
Seattle 79
Cambridge 66
Wilmington 65
Beijing 62
Ferrara 52
Nanjing 38
Izmir 34
New York 34
Brussels 27
Milan 20
Princeton 20
Shanghai 19
Addison 16
San Diego 16
Boardman 15
Bremen 13
Shenyang 11
Nanchang 8
Warsaw 8
Falls Church 6
Tianjin 6
Changsha 5
Dong Ket 5
Jinan 5
Augusta 4
Des Moines 4
Hebei 4
London 4
Ningbo 4
Dublin 3
Illasi 3
Jiaxing 3
Los Angeles 3
Norwalk 3
Hangzhou 2
Jakarta 2
Kunming 2
Mountain View 2
Orange 2
Redwood City 2
Acton 1
Anzola Dell'emilia 1
Ardabil 1
Berlin 1
Central 1
Colico 1
Edinburgh 1
Lanzhou 1
Leawood 1
Melbourne 1
Perth 1
Pescara 1
Redmond 1
Rome 1
Simi Valley 1
Stockholm 1
Tallinn 1
Velp 1
Venezia 1
Vienna 1
Washington 1
Zhengzhou 1
Totale 1.717
Nome #
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 176
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 150
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 125
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 124
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 122
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 120
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 119
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 116
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 116
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 113
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 113
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 111
Delirium in acute promyelocytic leukemia patients: two case reports. 110
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 105
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 100
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 97
null 88
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 87
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib 85
null 64
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 22
Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion 16
Totale 2.279
Categoria #
all - tutte 8.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019110 0 0 0 0 0 0 0 0 0 0 0 110
2019/2020508 77 15 23 75 38 56 56 42 53 40 20 13
2020/2021389 18 32 19 34 14 37 18 35 8 71 73 30
2021/2022267 32 15 8 8 13 15 30 10 9 24 33 70
2022/2023274 28 27 17 36 46 36 24 18 24 0 13 5
2023/2024109 11 13 5 3 3 43 8 8 2 2 1 10
Totale 2.279